Exelixis

YTD

ALL

Trade Exelixis 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About EXEL

Exelixis, Inc. operates as an oncology company, which focuses on discovering, developing, and commercialization of new medicines for difficult-to-treat cancers. Its products include cabometyx, cometriq, and cotellic.

CEO

Michael M. Morrissey

CEOMichael M. Morrissey

Employees

1,147

Employees1,147

Headquarters

Alameda, California

HeadquartersAlameda, California

Founded

1994

Founded1994

Employees

1,147

Employees1,147

EXEL Key Statistics

Market cap

12.58B

Market cap12.58B

Price-Earnings ratio

20.94

Price-Earnings ratio20.94

Dividend yield

—

Dividend yield—

Average volume

4.94M

Average volume4.94M

High today

$48.74

High today$48.74

Low today

$44.12

Low today$44.12

Open price

$44.38

Open price$44.38

Volume

6.04M

Volume6.04M

52 Week high

$49.62

52 Week high$49.62

52 Week low

$21.86

52 Week low$21.86

Analyst ratings

57%

of 21 ratings

Buy

57.1%

Hold

42.9%

Sell

People also own

Based on the portfolios of people who own EXEL. This list is generated using Robinhood data, and it’s not a recommendation.

Vertex Pharmaceuticals

VeriSign

Sprouts Farmers Market

United Therapeutics

Gilead Sciences

Novo Nordisk